Praleene Sivapalan, Karen Louise Ellekjaer, Anders Perner, Morten Hylander Møller, Anders Granholm, Lasse Grønningsæter, Marlies Ostermann, Rob Mac Sweeney, Maria Cronhjort, Johanna Hästbacka, Carmen Pfortmueller, Jan De Waele, Marek Nalos, Tomas Jovaisa, Annika Reintam Blaser, Maurizio Cecconi, Begum Ergan, Abdulrahman Al‐Fares, Paul J. Young, Wojciech Szczeklik, Eric Keus, Fayez Alshamsi, Ashish K. Khanna, Martin Ingi Sigurdsson, Tomoko Fujii, Yaseen M. Arabi, Tine Sylvest Meyhoff
{"title":"休克成人重症监护室患者使用白蛋白的偏好:一项国际调查","authors":"Praleene Sivapalan, Karen Louise Ellekjaer, Anders Perner, Morten Hylander Møller, Anders Granholm, Lasse Grønningsæter, Marlies Ostermann, Rob Mac Sweeney, Maria Cronhjort, Johanna Hästbacka, Carmen Pfortmueller, Jan De Waele, Marek Nalos, Tomas Jovaisa, Annika Reintam Blaser, Maurizio Cecconi, Begum Ergan, Abdulrahman Al‐Fares, Paul J. Young, Wojciech Szczeklik, Eric Keus, Fayez Alshamsi, Ashish K. Khanna, Martin Ingi Sigurdsson, Tomoko Fujii, Yaseen M. Arabi, Tine Sylvest Meyhoff","doi":"10.1111/aas.14479","DOIUrl":null,"url":null,"abstract":"IntroductionUse of albumin is suggested for some patients with shock, but preferences for its use may vary among intensive care unit (ICU) physicians.MethodsWe conducted an international online survey of ICU physicians with 20 questions about their use of albumin and their opinion towards a randomised trial among adults with shock comparing the use versus no use of albumin.ResultsA total of 1248 respondents participated, with a mean response rate of 37%, ranging from 18% to 75% across 21 countries. Respondents mainly worked in mixed ICUs and 92% were specialists in intensive care medicine. The reported use of albumin in general shock varied as 18% reported ‘almost never’, 22% ‘rarely’, 34% ‘occasionally’, 22% ‘frequently’ and 4% ‘almost always’ using albumin. In septic shock, 19% reported ‘almost never’, 22% ‘rarely’, 29% ‘occasionally’, 22% ‘frequently’ and 7% ‘almost always’ using albumin. Physicians’ preferences were more consistent for haemorrhagic‐ and cardiogenic shock, with more than 45% reporting ‘almost never’ using albumin. While the reported use of albumin for other purposes than resuscitation was infrequent (40%–85% reported ‘almost never’ for five other indications), the most frequent other indications were low serum albumin levels and improvement of the efficacy of diuretics. Most respondents (93%) would randomise adult ICU patients with shock to a trial of albumin versus no albumin.ConclusionsIn this international survey, the reported preferences for the use of albumin in adult ICU patients with shock varied considerably among surveyed ICU physicians. The support for a future randomised trial was high.","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2024-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Preferences for albumin use in adult intensive care unit patients with shock: An international survey\",\"authors\":\"Praleene Sivapalan, Karen Louise Ellekjaer, Anders Perner, Morten Hylander Møller, Anders Granholm, Lasse Grønningsæter, Marlies Ostermann, Rob Mac Sweeney, Maria Cronhjort, Johanna Hästbacka, Carmen Pfortmueller, Jan De Waele, Marek Nalos, Tomas Jovaisa, Annika Reintam Blaser, Maurizio Cecconi, Begum Ergan, Abdulrahman Al‐Fares, Paul J. Young, Wojciech Szczeklik, Eric Keus, Fayez Alshamsi, Ashish K. Khanna, Martin Ingi Sigurdsson, Tomoko Fujii, Yaseen M. Arabi, Tine Sylvest Meyhoff\",\"doi\":\"10.1111/aas.14479\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"IntroductionUse of albumin is suggested for some patients with shock, but preferences for its use may vary among intensive care unit (ICU) physicians.MethodsWe conducted an international online survey of ICU physicians with 20 questions about their use of albumin and their opinion towards a randomised trial among adults with shock comparing the use versus no use of albumin.ResultsA total of 1248 respondents participated, with a mean response rate of 37%, ranging from 18% to 75% across 21 countries. Respondents mainly worked in mixed ICUs and 92% were specialists in intensive care medicine. The reported use of albumin in general shock varied as 18% reported ‘almost never’, 22% ‘rarely’, 34% ‘occasionally’, 22% ‘frequently’ and 4% ‘almost always’ using albumin. In septic shock, 19% reported ‘almost never’, 22% ‘rarely’, 29% ‘occasionally’, 22% ‘frequently’ and 7% ‘almost always’ using albumin. Physicians’ preferences were more consistent for haemorrhagic‐ and cardiogenic shock, with more than 45% reporting ‘almost never’ using albumin. While the reported use of albumin for other purposes than resuscitation was infrequent (40%–85% reported ‘almost never’ for five other indications), the most frequent other indications were low serum albumin levels and improvement of the efficacy of diuretics. Most respondents (93%) would randomise adult ICU patients with shock to a trial of albumin versus no albumin.ConclusionsIn this international survey, the reported preferences for the use of albumin in adult ICU patients with shock varied considerably among surveyed ICU physicians. The support for a future randomised trial was high.\",\"PeriodicalId\":6909,\"journal\":{\"name\":\"Acta Anaesthesiologica Scandinavica\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2024-06-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Acta Anaesthesiologica Scandinavica\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/aas.14479\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ANESTHESIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Anaesthesiologica Scandinavica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/aas.14479","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
Preferences for albumin use in adult intensive care unit patients with shock: An international survey
IntroductionUse of albumin is suggested for some patients with shock, but preferences for its use may vary among intensive care unit (ICU) physicians.MethodsWe conducted an international online survey of ICU physicians with 20 questions about their use of albumin and their opinion towards a randomised trial among adults with shock comparing the use versus no use of albumin.ResultsA total of 1248 respondents participated, with a mean response rate of 37%, ranging from 18% to 75% across 21 countries. Respondents mainly worked in mixed ICUs and 92% were specialists in intensive care medicine. The reported use of albumin in general shock varied as 18% reported ‘almost never’, 22% ‘rarely’, 34% ‘occasionally’, 22% ‘frequently’ and 4% ‘almost always’ using albumin. In septic shock, 19% reported ‘almost never’, 22% ‘rarely’, 29% ‘occasionally’, 22% ‘frequently’ and 7% ‘almost always’ using albumin. Physicians’ preferences were more consistent for haemorrhagic‐ and cardiogenic shock, with more than 45% reporting ‘almost never’ using albumin. While the reported use of albumin for other purposes than resuscitation was infrequent (40%–85% reported ‘almost never’ for five other indications), the most frequent other indications were low serum albumin levels and improvement of the efficacy of diuretics. Most respondents (93%) would randomise adult ICU patients with shock to a trial of albumin versus no albumin.ConclusionsIn this international survey, the reported preferences for the use of albumin in adult ICU patients with shock varied considerably among surveyed ICU physicians. The support for a future randomised trial was high.
期刊介绍:
Acta Anaesthesiologica Scandinavica publishes papers on original work in the fields of anaesthesiology, intensive care, pain, emergency medicine, and subjects related to their basic sciences, on condition that they are contributed exclusively to this Journal. Case reports and short communications may be considered for publication if of particular interest; also letters to the Editor, especially if related to already published material. The editorial board is free to discuss the publication of reviews on current topics, the choice of which, however, is the prerogative of the board. Every effort will be made by the Editors and selected experts to expedite a critical review of manuscripts in order to ensure rapid publication of papers of a high scientific standard.